Focuses : Actualité Focuses en direct - P2 | Bourse Reflex
Accueil > Tags > Focuses

  • Toutes les actualités en rapport avec « Focuses »

15/09 18:00 Focuses - HALF-YEARLY RESULTS AT 30 JUNE 2015

28/07 18:00 Focuses - TURNOVER AT 30 JUNE 2015: EUR 295.0M

10/06 07:00 Focuses - Usine IO, the product prototyping and innovation platform, opens its capital to "French Tech Accélération" and Prodways Entrepreneurs

05/05 18:00 Focuses - TURNOVER AS OF 31 MARCH 2015: EUR 136.9 million

02/04 08:30 Focuses - Finalization of the agreement between William Demant and Holton

01/04 07:00 Focuses - After a successful financial restructuring, THEOLIA focuses on its development

17/03 18:00 Focuses - FISCAL YEAR 2014 RESULTS

17/02 08:35 Focuses - WILLIAM DEMANT ENTERS INTO EXCLUSIVE NEGOTIATIONS FOR THE PURCHASE OF A MAJORITY STAKE IN AUDIKA GROUPE, ONE OF THE FRENCH LEADERS IN HEARING CARE

03/02 18:10 Focuses - 2014 ANNUAL TURNOVER

06/10 08:00 Focuses - Partenariat stratégique entre HCL Technologies et CAST

15/09 08:35 Focuses - BM and FBOVESPA and BSM Choose NASDAQ OMX's SMARTS Integrity to Enhance Market Surveillance Operation

12/09 18:00 Focuses - Results for H1 2011

30/08 18:00 Focuses - MoCA Passes 100 Certified Products Milestone

28/07 18:00 Focuses - 2011 First-Half turnover

18/07 13:15 Focuses - Maxim Acquires SensorDynamics, Developer and Manufacturer of Proprietary Sensor and MEMS Solutions

06/07 12:35 Focuses - Raptor Pharmaceutical Receives Notices of Allowance for Two Key Patent Applications Protecting Its Cysteamine Portfolio

06/06 12:35 Focuses - Raptor Pharmaceutical Provides Update on Phase 3 Clinical Trial of DR Cysteamine for the Potential Treatment of Nephropathic Cystinosis

20/05 13:40 Focuses - Edward Lowe Foundation Receives USD 730,000 Grant From The NASDAQ OMX Educational Foundation for Research on Job Creation and Capital Access

10/05 18:00 Focuses - Turnover at 31 March 2011

24/01 12:30 Focuses - Raptor Pharmaceutical Completes Enrollment in Pivotal Phase 3 Clinical Trial of DR Cysteamine for the Potential Treatment of Nephropathic Cystinosis